TP53 and neoplasm: Aside from abolishing the tumor-suppressive capacities of the wild-type form, p53 mutations confer novel oncogenic functions that impact molecules and pathways, a phenomenon termed mutant p53 gain-of-function (GOF) (Kim and Lozano 2018; Nakayama et al. 2020).